Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Challenges and Breakthroughs in Neuropharmaceutics & Neuropharmacology
- Neuropharmaceutics 2017

About Neuropharmaceutics

Allied Academic Publication is an amalgamation of several esteemed academic and scientific association known for promoting scientific temperament. Established in the year 1997, Andrew John Publishing Group is a specialized Medical publisher that operates in collaboration with the association and societies. This publishing house has been built on the base of esteemed academic and research institutions including The College of Audiologists and Speech Language Pathologists of Ontario(CASLPO), The Association for Public Safety Communications Officials of Canada (APCO), The Canadian Vascular Access Association (CVAA), The Canadian Society of Internal Medicine (CSIM), The Canadian Hard of Hearing Association (CHHA), Sonography Canada, Canadian Association of Pathologists (CAP-ACP) and The Canadian Association of Neurophysiologic Monitoring(CANM)

Welcome Message

Neuropharmaceutics2017 is the premier international forum to present and grasp progress in field of research based studies, development, standards and applications of the Neuropharmaceutical and Neuropharmacological aspects in its broadways with its advancement in present Era. Offers high-quality technical studies, including research sessions, poster presentation sessions with brief demonstrations gaining knowledge. Neuropharmaceutics 2017 conference promises to be stimulating and inspirational experience in academic, professional and social spheres.

is the learning of how drugs influence cellular function in the nervous system, and the neural mechanisms through which they influence behavior. The studies are more concerned with the interactions of neurotransmitters, neuropeptides, neurohormones, neuromodulators, enzymes, second messengers, co-transporters, ion channels, and receptor proteins in the central and peripheral nervous systems. Advanced studies are being made to improvise developments in drugs to treat numerous diverse neurological disorders, including neurodegenerative diseases known to be Parkinson's disease and Alzheimer's disease, pain, addiction, psychological disorders and many more.

Market Analysis

Neuropharmaceutics 2017
 welcomes attendees, presenters, and exhibitors from all over the world to Rome, Italy. We are delighted to invite you all to attend and register for the 8th International Conference on Neuro Pharmaceutics and Neuro Pharmacology which is going to be held during December 07-08, 2017 at Rome, Italy.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Neuropharmaceutics 2017, where you will be sure to have a meaningful experience with scholars from around the world.

All the members’ of Neuropharmaceutics 2017 organizing committee look forward to meet you at Rome, Italy.



Importance and Scope:  

Neuropharmaceutics 2017 will be organized around the theme Challenges and Breakthroughs in Neuropharmaceutics & Neuropharmacology”.

Neuropharmacology is the study of how drugs affect cellular function in the nervous system, and the neural mechanisms through which they influence behavior. There are two main branches of neuropharmacology: behavioral and molecular. The emphasis of Neuropharmacology is on the study and understanding of the actions of known exogenous and endogenous chemical agents on neurobiological processes in the mammalian nervous system. It is necessary to focus on neuropharmacology and the use of neuropharmaceuticals to transform brain processes in the way of enhancing memory, mood, sensation, thinking and attention in people.

Neuropharmacology is a very broad region of science that encompasses many aspects of the nervous system from single neuron manipulation to entire areas of the brain, spinal cord, and peripheral nerves. To better understand the basis behind drug development, one must first understand how neurons communicate with one another.

        Neuropharmaceutics2017 focuses on discovery of therapeutic targets, and then translating those discoveries into drug and therapy development. Neuropharmaceutics is the largest potential growth sector of the pharmaceutical industry. However, this growth is blocked by the problem of the blood-brain barrier.

Why Rome, Italy?

Rome ranked as the 62nd in the world and the top in Italy in its World University Rankings. and currently ranks among Europe's 50 and the world's 150 best colleges. In order to decrease the overcrowding of La Sapienza, two new public universities were founded during the last decades: Tor Vergata in 1982 and Roma Tre in 1992. Rome hosts also the LUISS School of Government, Italy's most important graduate university in the areas of international affairs and European studies. Rome ISIA was founded in 1973 by Giulio Carlo Argan and is Italy's oldest institution in the field of industrial design.

Rome is a nationwide and major international center for higher education, containing numerous academies, colleges and universities. It boasts a large variety of academies and colleges, and has always been a major worldwide intellectual and educational center, especially during Ancient Rome and the Renaissance, along with Florence. According to the City Brands Index; Rome is considered the world's second most historically, educationally and culturally interesting and beautiful city Neuro Pharmaceutics and Neuro Pharmacology conference is an opportunity to bring around the world focused on learning about Neuropharmaceutics. The conference brings together some of the latest, most thought-provoking research from around the world. In a small and intimate setting, researchers and clinicians from all corners of the world are able to exchange ideas, share findings and discuss future collaborations. This will produce a broader international knowledge-base and wonderful advances in the field of Neuro Pharmaceutics and Neuro Pharmacology. World-renowned speakers, the most recent techniques, and the newest updates in Neuro Pharmaceutics and Neuro Pharmacology are hallmarks of this conference.

Why to attend?

8th International Conference on Neuro Pharmaceutics and Neuro Pharmacology is a unique platform which aims to generate new ideas for Neuropharmaceutics that will be beneficial across the globe. Neuropharmaceutics 2017 will witness an assembly of experts from all over the world who will present their current cutting edge research for the betterment in this aspect.

Conference Highlights


Importance of Neuropharmaceutics

Chemical signaling systems in CNS

Targets of Drug action in CNS

Importance of Blood Brain Barriers in CNS

Neurochemical Intereactions

Molecular Neuropharmacology

Neurotransmission process

Behavioural Neuropharmacology

Neuroendocrine Integration

Impact of Neuroscience on Neuro ethics

Neuro immune Methodology

Neuro technological studies

Applications of Neuropharmacology

Future Goals of Neuropharmacology

Clinical Trials

Institutes funding for Research

The statistic depicts the research and development expenditure of the entire pharmaceutical   industry of the United States from 1995 to 2014.

In  2004, the expenditure of the entire U.S. pharmaceutical industry on research and development came to 47.6 billion U.S. dollars. The US National Institutes of Health fund a Neuropharmacology Laboratory project, Universidad Pompeii Fabre, Barcelona

Neuropharmacology Program, the National Institute of Mental Health (NIMH) McKnight Endowment Fund for Neuroscience

The statistic depicts the research and development expenditure of the entire pharmaceutical   industry of the United States from 1995 to 2014. In 2004, the expenditure of the entire U.S. pharmaceutical industry on research and development came to 47.6 billion U.S. dollars.

Market Capitalization of Neuropharmaceutical Companies:       

In 2014, investors provided $3.3 billion into firms that are developing drugs for brain-destroying or psychiatric illnesses. Some big drug companies, including Johnson & Johnson, Roche and Novartis, are finding ways to reinvigorate their efforts. New medicines for severe depression, psychosis and schizophrenia could reach the market within the next few years, and treatments for Alzheimer’s, Parkinson’s and some forms of autism are a real possibility, too.

Session Discussion

Sessionon:  Neuro pharmaceutics

Non-drug reinforces areexponentially equal to that of behavioral approach to drug addiction that arenot quantitatively different. The studies which include Molecular,Biological, and Morphological changes which accompanies abuse drug can also beestimated by behavioral studies. One major advantage of this approach to drugabuse is that it accounts for excessive behavior which does not involve drugsor dosage forms, but also it accounts for situations in which there existsrepeated exposure to drugs which is not followed by  addiction. 

Sessionon: Importance of Neuropharmaceutics

     Neuropharmaceutics is the learning of how drugs influence cellular function in the nervous system,and the neural mechanisms through which they influence behavior. The studiesare more concerned with the interactions of neurotransmitters, neuropeptides,neurohormones, neuromodulators, enzymes, second messengers, co-transporters,ion channels, and receptor proteins in the central and peripheral nervoussystems. Advanced studies are being made to improvise developments in drugs totreat numerous diverse neurological disorders, including neurodegenerativediseases known to be Parkinson's disease and Alzheimer's disease, pain,addiction, psychological disorders and many more.

Sessionon: Chemical signaling in CNS

Neurotransmitters aregenerated mainly at the region of presynaptic clefts which are produce at post synapticregions with excitatory and inhibitory actions.  Non neuronal cellsreleases Neurotropic factors that acts majorly on kinase-linked receptors(Tyrosine) which have regulatory action on genome expression. It also controlsgrowth of phenotypic characteristics. Neurons communicate with the help ofchemical and electrical signaling which allows signals driven capabilities forconduction in end to end cells. This conduction process takes place inside theneuronal cell, at the gaps present in-between which is termed as synapses.Communication between neurons occurs at tiny gaps called synapses. Chemicaltransmission majorlytakes place in between the pre-synaptic and post-synaptic regions of neuronswhich are extendedly interconverted with their tendency from initial to finalstages. Alteration in post synaptic neurons occurs when a neurotransmittermolecule binds to the receptor proteins.  Ligand-gated ion channels andG-protein couple  receptors  allows rapid ion flow to the outer cellmembrane regions The neurotransmitter molecules bind to the receptor proteinsand alter postsynaptic neuronal function. Neurotrophins and steroidal hormonesmainly influence the function and development of the neurons and neuronalmembranes.

Sessionon: Targets for chemical transmission

Drug mainly targetsenzymes and receptor regions in the form of proteins and nucleic whichactivities can be modified relatedly by a dosage regimen i.e. drug whoseactivity can be modified by a drug. The drug could a low –molecular weightchemically inert compound or a biological compound as a recombinant protein oran antibody such as an antibody or a recombinant protein. The targets of Drugshould show chemical, mechanical and biological responses including theirin-vitro and in-vivo methods relevant to diseases. And where the mainNeurotransmitters chemical target includes mainly GABA, Glutamate etc. thatoperates through functioning of Neuromodulators like 5 Epinephrine,prostanoids. 5-hydroxytryptamine, acetylcholine that act through both ligand-gated channels and G-protein-coupled receptors. Functions as function as bothneuromodulator and neurotransmitter.  Lipid Solubility and Binding Siteare the factors for chemical signaling variations. Intracellular receptoroccupies hydrophobic chemical signals to cell surfaces. Agonists andantagonists a modify receptor activity. Receptor Activity can also modified byAgonists and Antagonists. Chemical signaling takes placethrough blood or other fluids, but are slow in functioning processes.  Thecell body, Dendrites, Axon are the major regions for integration of signals inneuronal and organelle regions. 

Sessionon: Importance of Blood Brain Barriers

The term blood-brainbarrier has a significant importance. It describes the morphological, molecularand physiological functioning that controls efflux and influx of molecules inbetween the blood streams and brain.  This mechanisms results a stableinternal environment of brain with characteristics. The major role ofblood-brain barrier (BBB) is to protect the neural tissue from variations whenoccurred in blood composition and toxins.    The control oversubstance which enters or leaves the brain regions is done by endothelial cellsthat form blood - brain barriers. In adult’s complex cellular systems withbasal membrane and number of pericytes, astrocytes are embedded.  There isa differentiation in endothelial cells of brain and endothelial cells ofdifferent organs in two ways:  Prevention of Para cellular movement ofmolecules and confirmation of no detectable Tran’s endothelial pathways thebasal and specific proteins present in membrane are involved in the developmentof blood brain barrier. Astrocyte foot processes contributes for brain swellingthat allow water intake. Movement of solutes into the brain is done by transportcarriers mainly for glucose and amino acids (essential). Efflux of smallermolecules and mainly non-essential amino acids from the region of brain toblood is caused by secondary transport systems. They control the entry of neurotransmitters to brain.

Mainly the hypofunctioning processes of neurotransmitter like serotonin moiety represent  biochemical traits that evaluate individuals to cause impulsiveaggression, with dopamine which contributes in an additive nature toserotonergic deficits. Neurons can also be termed as excitable cells dueto the reason that its surface membrane consists of ions which are made up ofabundant number of protein molecules.  The Neuron and neuronalstructures allows chemical signals through axon terminals. Receptor based interactions in neuropharmacological studies are mostly useful in drugs with disruption ofbinding process.

Sessionon: Molecular Neuropharmacology

It includes the studyof morphological aspects and configurationally studies of agonists andantagonists (competitive and non-competitive) in order to develop new drugdosage regimens to treat neurodegenerative disorders. Growth anddevelopment of neurons is termed to be neurogenesis. Neurons does not functionin isolative process, they are been organized into circuits which allow severalkinds of information as neuronal circuits. Major functioning neurotransmitterincludes GABA and serotonin in thecentral nervous system of vertebrate. About 14 types of5-hydrogen tryptamine receptor subtypes have been modulated, which activatesproteins.

Sessionon: Neurotransmission Process

Process of Neurotransmission majorly takes place through following stages: Synthesis ofneurotransmitter, storage of neurotransmitter in axon terminals, formation ofsynaptic cleft, release of neurotransmitter, degradation or deactivation ofneurotransmitter. After the release of neurotransmitter a sequential incidenceof its entrance into the synaptic cleft from pre-synaptic region topost-synaptic region takes place that could be further combined with ionic orG-coupled proteins.  Agonization can be done by ligand basedmechanism. The phenomenon Co-transmission includes replaceof nerve terminals with neurotransmitters.

Sessionon: Behavioral Neuropharmacology

It is concerned withcomplete and keen knowledge of neuronal and pharmacological based mechanisms ofbehavioral aspects along with its abnormalities that results to neuropsychiatriceffect. 

Sessionon: Neuroendocrine Integration

Interactionsbetween the nervous system and the endocrinesystem takes place in this including biological interactions of the cellalso takes place. Prominent researches on Insulin receptor and hypothalamicprogramming plays a crucial role in neuroendocrine integration.Transport, synthesisand secretion of hormones, Interactions between the nervous, endocrine,and immune systems Genetics of endocrinology including chemicalsignaling mechanisms. All endocrine glands are innervated by autonomicnerves and these may directly control their endocrine function and/or regulateblood flow (or hence function) within the gland. Hormones may affect CNSfunctions such as mood, anxiety and behavior. The concept of clinical neuroendocrinology has been greatlyfacilitated the technological progress in imaging techniques like MR and CTscanning

Sessionon: Impact of Neuroscience on Neuro ethics

For ethical issueadvancements in the neuroscience, historical and emerging trends inneuroimaging, using functional magnetic resonance imaging (fMRI) as a model ismostly used. Whereas Functional MRI has impact on the neurosciences in the pastdecade that resulted its wide availability coupling of spatial resolution, andapplication to a broad range of clinical neurobehavioral phenomenon. Thephilosophical discussion of behavior and mental function is an ancienttradition that informs and complicates the emerging field of NeuroethicsTheneurocognitive ethics includes interventions and imagining of brainand neurological treatments and consciousness disorders.

Sessionon: Neuro Immune Methodology

This methodology is concerned with the interactions in between immunological and nervous systemfunctions along with autoimmune diseases.  Cortical system includesthe study of mapping neural and neuronal systems associated in thepropagating of emotion. It also focuses on the components of cortical systemswith the process of recognizing facial expressions.. A disorder in whichspinal cord is affected known as Transverse myelitis which is heterogeneouslyinflammatory in actions. Whereas Encephalitis cause acuteinflammation of brain resulted from an auto immune or viral infection .A progressive brain disorder  Huntington’s disorder that causesuncontrolled movements, emotional problems, and loss of thinking ability.

Sessionon: Neuro Technological Studies

Neurotechnological tools arethe valuable objective to differentiate patterns of cerebral activity inpatients suffering from drug of choice. Other functional Neuro-imagingtechnologies like Electroencephalography, Magneto encephalography, Functionalmagnetic resonance imaging facilitate researchers to assess residualconsciousness in patients with drug choice. The major prospects ofare to detect theoretically and clinically promising, but theassumption of residual consciousness that raises ethically accepted challenges.

Sessionon: Applications of Neuropharmacology

publishes original and high quality research within the disciplineof neuroscience.The emphasis on neuropharmacological studies is tounderstand the actions of exogenous and endogenous chemical agents onneurobiological processes in nervous systems of humans. New drugs arediscovered for the advances in molecular biology and wide variety ofdiscoveries in the neurosciences has helped to build the foundations forknowing in brief about Neuropharmacology. Chemical Neuro anatomy and Neuropharmacology helped in discovery of major neurotransmitters in CNS and theirrelated mechanisms.

Sessionon: Future goals of Neuropharmacology

SAR’s (structuralactivity relationship studies) includes a major area of research in neuropharmacology which is an attempt to modify the effect or the potent drugsand their activities in relation to modification of their chemical andbiochemical structures. Moreover after several investigating studies the molecular roles of delta FosB have been initiated by Neurotechnological epigenetic studies with recent advances.

Sessionon: Clinical Trials

  Clinical trials are conducted in order to examining case studies. Carrying out clinical trials for neuropharmacological studies has become a major challenge at a number of levels. Numerous clinical interactions help us to frame queries for more rigorously designed clinical studies.  Clinical researches provide valuable teaching guidance which demonstrates both classical and unusual presentations for challenges to practitioners.


Organizing Committee Members
OCM Member
Ljudmila Stojanovich, MD, PhD, FRCP
Head of Scientific Research Board, Internal medicine-rheumatologist
University of Belgrade
 Beograd, Serbia
OCM Member
Professor Sam Lingam
Executive Medical Director Consultant in Paediatrics and Adolescent Medicine , Executive Medical Director Consultant in Paediatrics and Adolescent Medicine
St. Eustatius University Medical School
London, United Kingdom
OCM Member
Prof. Md Sirajul Islam
Director, Director Holy Family Red Crescent Medical College Eskaton, Dhaka
Director, Holy Family Red Crescent
Dhaka, Bangladesh
OCM Member
Member, Global Advisory Committee on Vaccine Safety, WHO, Geneva , Adjunct Professor, Maharashtra University of Health Sciences, Nashik
Director of Medical Education & Research, Govt. of Maharashtra
Mumbai, India
OCM Member
Dr. Subashchandrabose Chinnathambi
National Chemical Laboratory, Biochemical Sciences Division
National Chemical Laboratory
Mumbai, India
OCM Member
Dr. Mesbah Uddin Ahmed
Associate Professor & Head,Department of Paediatrics, Gonosasthya Somaj-vittick Medical College, Savar, Dhaka, Bangladesh
Secretary General, Bangladesh Paediatric Association
Dhaka, Bangladesh
OCM Member
Dr. Uday Govindrao Bodhankar
International Council Member ASPR Japan
Nagpur, India

To Collaborate Scientific Professionals around the World

Conference Date December 7-8, 2017
Speaker Oppurtunity
Poster Oppurtunity Available
e-Poster Oppurtunity Available

Join The Discussion

Authorization Policy

Copyright © 2017-2018 Allied Academies, All Rights Reserved.